IRRAS Toekomstige groei
Future criteriumcontroles 2/6
IRRAS is forecast to grow earnings and revenue by 96.4% and 84.7% per annum respectively.
Belangrijke informatie
96.4%
Groei van de winst
n/a
Groei van de winst per aandeel
| Medical Equipment winstgroei | 15.7% |
| Inkomstengroei | 84.7% |
| Toekomstig rendement op eigen vermogen | n/a |
| Dekking van analisten | Low |
| Laatst bijgewerkt | 03 Jan 2024 |
Recente toekomstige groei-updates
Recent updates
Winst- en omzetgroeiprognoses
| Datum | Inkomsten | Inkomsten | Vrije kasstroom | Geldmiddelen uit operationele activiteiten | Gem. Aantal analisten |
|---|---|---|---|---|---|
| 12/31/2024 | 249 | -30 | N/A | N/A | 1 |
| 12/31/2023 | 165 | -101 | N/A | N/A | 1 |
| 6/30/2023 | 43 | -196 | -195 | -192 | N/A |
| 3/31/2023 | 43 | -193 | -197 | -193 | N/A |
| 12/31/2022 | 40 | -167 | -179 | -176 | N/A |
| 9/30/2022 | 37 | -164 | -160 | -157 | N/A |
| 6/30/2022 | 32 | -141 | -133 | -129 | N/A |
| 3/31/2022 | 27 | -131 | -134 | -129 | N/A |
| 12/31/2021 | 22 | -136 | -138 | -131 | N/A |
| 9/30/2021 | 18 | -131 | -131 | -123 | N/A |
| 6/30/2021 | 14 | -135 | -134 | -125 | N/A |
| 3/31/2021 | 10 | -140 | -139 | -129 | N/A |
| 12/31/2020 | 7 | -136 | -141 | -133 | N/A |
| 9/30/2020 | 8 | -134 | -151 | -144 | N/A |
| 6/30/2020 | 7 | -139 | -159 | -152 | N/A |
| 3/31/2020 | 7 | -147 | -166 | -152 | N/A |
| 12/31/2019 | 5 | -151 | -169 | -154 | N/A |
| 9/30/2019 | 2 | -165 | -159 | -138 | N/A |
| 6/30/2019 | 1 | -171 | -146 | -125 | N/A |
| 3/31/2019 | 0 | -160 | -130 | -116 | N/A |
| 12/31/2018 | 6 | -139 | -112 | -97 | N/A |
| 9/30/2018 | 7 | -112 | -103 | -95 | N/A |
| 6/30/2018 | 18 | -78 | -90 | -82 | N/A |
| 3/31/2018 | 18 | -67 | -78 | -68 | N/A |
| 12/31/2017 | 12 | -61 | -65 | -54 | N/A |
| 9/30/2017 | 11 | -48 | -53 | -35 | N/A |
| 12/31/2016 | N/A | -32 | N/A | -18 | N/A |
| 12/31/2015 | N/A | -13 | N/A | -11 | N/A |
Toekomstige groeivoorspellingen analisten
Verdiensten versus spaarpercentage: 4Z7 is forecast to remain unprofitable over the next 3 years.
Winst versus markt: 4Z7 is forecast to remain unprofitable over the next 3 years.
Hoge groeiwinsten: 4Z7 is forecast to remain unprofitable over the next 3 years.
Omzet versus markt: 4Z7's revenue (84.7% per year) is forecast to grow faster than the German market (4.7% per year).
Hoge groei-inkomsten: 4Z7's revenue (84.7% per year) is forecast to grow faster than 20% per year.
Groeiprognoses winst per aandeel
Toekomstig rendement op eigen vermogen
Toekomstige ROE: Insufficient data to determine if 4Z7's Return on Equity is forecast to be high in 3 years time